Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

NCT03948568 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

262

Enrollment

OTHER

Sponsor class

Conditions

Early-stage Breast Cancer

Interventions

COMBINATION_PRODUCT: Endocrine Therapy and Radiotherapy

Sponsor

Ottawa Hospital Research Institute